Shover C, Falasinnu T, Dwyer C, Benitez Santos N, Cunningham N, Freedman R, Vest N, Humphreys K. Steep increases in fentanyl-related mortality west of the Mississippi River. Drug Alcohol Depend. 2020 Nov 1.
Shover C, Davis C, Gordon S, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci USA. 2019 Jun 10.
Shover C, DeVost M, Beymer M, Flynn R, Gorbach P, Bolan R. Using sexual orientation and gender identity (SOGI) to monitor disparities in HIV, sexually transmitted infections, and viral hepatitis. Am J Public Health. 2018 Nov 01: S277-S283.
Shover C, Falasinnu T, Freedman R, Humphreys K. Emerging characteristics of isotonitazene-involved overdose deaths: a case-control study. J Addict Med. In press.
Shover C. Availability of extended-release buprenorphine to treat opioid use disorder for Medicaid-covered population. Psychiat Serv. 2020 Sep 10.
Shover C, Vest N, Chen D, Stueber A, Falasinnu T, Hah J, Kim J, Mackey I, Weber K, Ziadni M, Humphreys K. Association of state policy allowing medical cannabis for opioid use disorder with dispensary marketing for this indication. JAMA Netw Open. 2020 Jul 14.
Humphreys K and Shover C. Recreational cannabis legalization presents an opportunity to reduce the harms of the U.S. medical cannabis industry. World Psychiatry. 2020 May 11.
Caputi T, Shover C, Watson R. Physical and Sexual Violence among U.S. Gay, Lesbian, Bisexual, and Questioning Adolescents, 2015-2017. JAMA Pediatr. 2020 Mar 9.
Shover C, Humphreys K. Six policy lessons relevant to cannabis legalization. American Journal of Drug and Alcohol Abuse. 2019 Mar 14. doi1080/00952990.2019.1569669. [Epub ahead of print]
Wall-Wieler E, Shover C, Hah J, Carmichael S, Butwick A. Opioid prescription and persistent opioid use after ectopic pregnancy. Obstet Gynecol. 2020 Sep 1.
Shover C. Commentary on Larance et al. (2020): Priorities and concerns of people who use opioids are key to scaling up XR-buprenorphine. Addiction. 2020 Apr 18.
Shover C, Humphreys K. Predictors of availability of long-acting medication for opioid use disorder. Drug Alcohol Depend. 2019 Sep 25.
Shover C, Abraham A, D’Aunno T, Friedmann P, Humphreys K. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs. J Subs Abuse Treat. 2019 Jul 29.
Lee JG, DeMarco ME, Beymer MR, Shover C, Bolan RK. Tobacco-free policies and tobacco cessation systems at health centers serving lesbian, gay, bisexual, and transgender clients. LGBT Health. 2018;5(4):264-269. doi: 10.1089/lgbt.2017.0208. Epub 2018 Apr 16.
Shover C, DeVost M, Cunningham N, Beymer M, Flores D, Flynn R, Gorbach P, Lyman P, Amico KR, Bolan R. Structural, dosing, and risk change factors affecting discontinuation of pre-exposure prophylaxis (PrEP) in a large urban clinic. AIDS Educ Prev. 2020: doi:10.1521/aeap.2020.32.4.271
Shover C and Humphreys K. Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model? Cureus. 2020 Jun 17
Shover C, Javanbahkt M, Shoptaw S, Lee S-J, Bolan R, Cunningham N, Beymer M, DeVost M, Gorbach P. Mind the Gaps: Prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California. AIDS Behav 2019 Apr 5.
Shover C, Javanbahkt M, Shoptaw S, Lee S-J, Bolan R, Parsons J, Rendina J, Gorbach P. HIV pre-exposure prophylaxis initiation at a large community clinic: Differences between eligibility, awareness, and uptake. Am J Public Health 2018 Aug 23:e1-e10.
Beymer M, DeVost M, Weiss R, Dierst-Davies R, Shover C, Benasians C, Talan A, Flynn R, Krysiak R, McLaughlin K, Bolan R. Does HIV Pre-Exposure Prophylaxis Use Lead to a Higher Incidence of Sexually Transmitted Infections? A Case-Crossover Study of Men Who Have Sex with Men in Los Angeles, California.Sexually Transmitted Infections. 2018 Sep;94(6):457-462.
Gorbach, P, Javanbakht M, Shover C, Bolan R, Ragsdale A, Shoptaw S. Associations Between Cannabis Use, Sexual Behavior, and STIs/HIV In a Cohort of Young Men Who Have Sex with Men. Sexually Transmitted Diseases. 2018 Oct. 01 doi:10.1097/OLQ.0000000000000919. [Epub ahead of print]
Shover C, Beymer M, Unger E, Javanbahkt M, Bolan R. Accuracy of Presumptive Gonorrhea Treatment for Gay and Bisexual Men: Results from a Large Sexual Health Clinic in Los Angeles, California. LGBT Health. 2018;5(2):139-144. doi: 10.1089/lgbt.2017.0115. Epub 2018 Mar 01.
DeVost M, Beymer M, Weiss R, Shover C, Bolan R. App-Based Sexual Partner Seeking and Sexually Transmitted Infection Outcomes: A Cross-Sectional Study of HIV-negative MSM Attending an STI Clinic in Los Angeles, California. Sexually Transmitted Diseases. 2018 Jun;45(6):394-399. doi: 10.1097/OLQ.0000000000000770.
Maitino E, Shafir S, Beymer M, Shover C, Cunningham N, Flynn R, Bolan R. Age at First HIV Test for MSM at a Community Health Clinic in Los Angeles. AIDS Care. In press.
Shackett B, Blanco J, Hightow-Weidman L, Mgodi N, Alcami J, Buchbinder S,…, Shover C, et al. HIVR4P 2018: From Research to Impact Conference Summary and Highlights. AIDS Research and Human Retroviruses. 2019 May 29. [Epub ahead of print].
Beymer M, Harawa N, Weiss R, Shover C, Toynes B, Meanley S, Bolan R. Are partner race and intimate partner violence associated with incident and newly diagnosed HIV infection in African-American men who have sex with men? Journal of Urban Health. 2017 Jun 14. doi: 10.1007/s11524-017-0169-7.
Cunningham N, Beymer M, Javanbahkt, M, Shover C, Bolan R. Concordance between self-reported STI history and biomedical results among men who have sex with men in Los Angeles, California. Sexually Transmitted Infections Nov 2017;93:514-519.
Copyright © 2019 Chelsea L. Shover, PhD - All Rights Reserved.